In this study, we assessed the effect of the experimental Syk inhibitor BI (Boehringer Ingelheim)-1002494 on platelet and neutrophil recruitment to the lungs, liver, spleen, and kidney in SCD mice, both at baseline and following hemin treatment. This evidence concerns the gene SYK and Schnyder corneal dystrophy.